Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Nicotine percentage replacement among smokeless tobacco users with nicotine patch.

Ebbert JO, Post JA, Moyer TP, Dale LC, Schroeder DR, Hurt RD.

Drug Alcohol Depend. 2007 Jul 10;89(2-3):223-6. Epub 2007 Feb 14.

2.

Effect of high-dose nicotine patch therapy on tobacco withdrawal symptoms among smokeless tobacco users.

Ebbert JO, Dale LC, Patten CA, Croghan IT, Schroeder DR, Moyer TP, Hurt RD.

Nicotine Tob Res. 2007 Jan;9(1):43-52.

PMID:
17365735
3.

A randomized phase II clinical trial of high-dose nicotine patch therapy for smokeless tobacco users.

Ebbert JO, Croghan IT, Schroeder DR, Hurt RD.

Nicotine Tob Res. 2013 Dec;15(12):2037-44. doi: 10.1093/ntr/ntt097. Epub 2013 Jul 19.

4.

High-dose nicotine patch therapy. Percentage of replacement and smoking cessation.

Dale LC, Hurt RD, Offord KP, Lawson GM, Croghan IT, Schroeder DR.

JAMA. 1995 Nov 1;274(17):1353-8.

PMID:
7563559
5.

Residential treatment for smokeless tobacco use: a case series.

Ebbert JO, Dale LC, Vickers KS, Gauvin TR, Bunge NE, Hurt RD.

J Subst Abuse Treat. 2004 Jun;26(4):261-7.

PMID:
15182890
6.

Effects of treatment on cardiovascular risk among smokeless tobacco users.

Allen SS, Hatsukami D, Jensen J, Grillo M, Bliss R.

Prev Med. 1995 Jul;24(4):357-62.

PMID:
7479625
7.

Nicotine lozenges for the treatment of smokeless tobacco use.

Ebbert JO, Dale LC, Severson H, Croghan IT, Rasmussen DF, Schroeder DR, Vander Weg MW, Hurt RD.

Nicotine Tob Res. 2007 Feb;9(2):233-40.

PMID:
17365754
8.

Cotinine replacement levels for a 21 mg/day transdermal nicotine patch in an outpatient treatment setting.

Gariti P, Alterman AI, Barber W, Bedi N, Luck G, Cnaan A.

Drug Alcohol Depend. 1999 Apr 1;54(2):111-6.

PMID:
10217550
9.

A randomized clinical trial of nicotine lozenge for smokeless tobacco use.

Ebbert JO, Severson HH, Croghan IT, Danaher BG, Schroeder DR.

Nicotine Tob Res. 2009 Dec;11(12):1415-23. doi: 10.1093/ntr/ntp154. Epub 2009 Oct 30.

10.

The Fagerström Test for Nicotine Dependence-Smokeless Tobacco (FTND-ST).

Ebbert JO, Patten CA, Schroeder DR.

Addict Behav. 2006 Sep;31(9):1716-21. Epub 2006 Jan 31.

11.

Cotinine as a biomarker of systemic nicotine exposure in spit tobacco users.

Ebbert JO, Dale LC, Nirelli LM, Schroeder DR, Moyer TP, Hurt RD.

Addict Behav. 2004 Feb;29(2):349-55.

PMID:
14732423
12.

Bupropion SR for the treatment of smokeless tobacco use.

Dale LC, Ebbert JO, Glover ED, Croghan IT, Schroeder DR, Severson HH, Hurt RD.

Drug Alcohol Depend. 2007 Sep 6;90(1):56-63. Epub 2007 Mar 13.

13.

Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement.

Hurt RD, Dale LC, Fredrickson PA, Caldwell CC, Lee GA, Offord KP, Lauger GG, Marŭsić Z, Neese LW, Lundberg TG.

JAMA. 1994 Feb 23;271(8):595-600.

PMID:
8301791
14.

Escalating doses of transdermal nicotine in heavy smokers: effects on smoking behavior and craving.

Selby P, Andriash K, Zawertailo L, Persad D, Zack M, Busto UE.

J Clin Psychopharmacol. 2013 Oct;33(5):667-74. doi: 10.1097/JCP.0b013e31829a829d.

PMID:
23963055
15.

Weight change after smoking cessation using variable doses of transdermal nicotine replacement.

Dale LC, Schroeder DR, Wolter TD, Croghan IT, Hurt RD, Offord KP.

J Gen Intern Med. 1998 Jan;13(1):9-15.

16.

A pilot study of mailed nicotine lozenges with assisted self-help for the treatment of smokeless tobacco users.

Ebbert JO, Severson HH, Croghan IT, Danaher BG, Schroeder DR.

Addict Behav. 2010 May;35(5):522-5. doi: 10.1016/j.addbeh.2009.12.020. Epub 2010 Jan 4.

17.

Comparative effectiveness of the nicotine lozenge and tobacco-free snuff for smokeless tobacco reduction.

Ebbert JO, Severson HH, Croghan IT, Danaher BG, Schroeder DR.

Addict Behav. 2013 May;38(5):2140-5. doi: 10.1016/j.addbeh.2013.01.023. Epub 2013 Feb 4.

18.

Characteristics of smokeless tobacco users seeking treatment.

Hatsukami DK, Jensen J, Boyle R, Grillo M, Bliss R.

Addict Behav. 1999 Jul-Aug;24(4):551-7.

PMID:
10466850
19.

Effects of behavioral and pharmacological treatment on smokeless tobacco users.

Hatsukami D, Jensen J, Allen S, Grillo M, Bliss R.

J Consult Clin Psychol. 1996 Feb;64(1):153-61.

PMID:
8907095
20.

Measuring nicotine dependence among smokeless tobacco users.

Thomas JL, Ebbert JO, Patten CA, Dale LC, Bronars CA, Schroeder DR.

Addict Behav. 2006 Sep;31(9):1511-21. Epub 2006 Jan 4.

PMID:
16386854

Supplemental Content

Support Center